- First quarter 2024 net loss of $41.6
million, or Limited partners' interest of $0.51 basic net loss per unit
- First quarter 2024 Adjusted EBITDA of $21.6 million
- Plan to convert structure from a Master Limited Partnership to
a C-Corp is on track
- Montana Renewables ("MRL") improved sequentially through the
quarter, posted positive EBITDA in March
2024, and operated at planned production levels in
April
- MRL remains the largest SAF producer in the Western Hemisphere
with 30 million gallons annual capacity
- Shreveport turnaround completed successfully during the first
quarter of 2024
INDIANAPOLIS, May 10, 2024
/PRNewswire/ -- Calumet Specialty Products Partners, L.P. (NASDAQ:
CLMT) (the "Partnership," "Calumet," "we," "our" or "us"), today
reported results for the first quarter ended March 31, 2024,
as follows:
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
2024
|
|
2023
|
|
(Dollars in millions, except per unit data)
|
Net income
(loss)
|
$
|
(41.6)
|
|
$
|
18.6
|
Limited partners'
interest basic net income (loss) per unit
|
$
|
(0.51)
|
|
$
|
0.23
|
Adjusted
EBITDA
|
$
|
21.6
|
|
$
|
77.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Specialty Products and Solutions
|
|
Performance Brands
|
|
Montana/Renewables
|
|
|
Three Months Ended
March 31,
|
|
Three Months Ended
March 31,
|
|
Three Months Ended
March 31,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
(Dollars in millions, except per barrel data)
|
Gross profit
(loss)
|
|
$
|
85.3
|
|
$
|
109.9
|
|
$
|
22.3
|
|
$
|
23.6
|
|
$
|
(29.1)
|
|
$
|
(36.9)
|
Adjusted
EBITDA
|
|
$
|
41.8
|
|
$
|
76.0
|
|
$
|
13.4
|
|
$
|
16.4
|
|
$
|
(14.5)
|
|
$
|
4.8
|
Gross profit (loss) per
barrel
|
|
$
|
15.77
|
|
$
|
21.22
|
|
$
|
154.86
|
|
$
|
185.83
|
|
$
|
(14.16)
|
|
$
|
(22.91)
|
"We're anticipating an exciting and strategically important
spring and summer at Calumet as we remain on pace to complete our
C-Corp conversion and demonstrate the competitive advantages of
Montana Renewables. Further, our DOE loan process and MaxSAF
project preparation are progressing well," said Todd Borgmann, CEO. "We enter the second quarter
with solid operating momentum after executing a successful
turnaround at our Shreveport facility and sequential monthly
financial and operational improvement at Montana Renewables.
MRL ended the first quarter by generating positive EBITDA in March,
which continued into April. First quarter financial results were
also affected by the sharp run-up in crude price that compressed
specialty and wholesale asphalt margins, and by the annual winter
closure of our Montana retail
asphalt rack, which is now open and gearing up for the paving
season."
Specialty Products and Solutions (SPS): The SPS segment
reported Adjusted EBITDA of $41.8
million during the first quarter of 2024 compared to
Adjusted EBITDA of $76.0 million for
the same quarter a year ago, largely due to a return to near
mid-cycle levels in the fuel market.
Performance Brands (PB): The PB segment reported
Adjusted EBITDA of $13.4 million
during the first quarter of 2024. This compares to Adjusted EBITDA
of $16.4 million in the first quarter
of 2023, which included the receipt of a $5.0 million insurance claim.
Montana/Renewables (MR):
The MR segment reported $(14.5)
million of Adjusted EBITDA during the first quarter of 2024
compared to Adjusted EBITDA of $4.8
million in the prior year period. First quarter results
reflect the impact of old, high priced inventory in our Montana
Renewables business, while our specialty asphalt refinery saw
seasonal weakness in fuels and compressed realizations in wholesale
asphalt which lagged the sharp run up in crude cost.
Corporate: Total corporate costs represent $(19.1) million of Adjusted EBITDA for the first
quarter 2024. This compares to $(19.9)
million of Adjusted EBITDA in the first quarter 2023.
2029 Secured Notes: On March 7,
2024, the Company issued and sold $200.0 million in aggregate principal amount of a
new series of the Issuers' 9.25% Senior Secured First Lien Notes
due 2029 (the "2029 Secured Notes") in a private placement
transaction in reliance on an exemption from registration under
Section 4(a)(2) of the Securities Act of 1933, as amended (the
"Securities Act"). The 2029 Secured Notes were issued at par for
proceeds of $200.0 million, before
estimated transaction expenses. The Company used the net proceeds
from the private placement of the 2029 Secured Notes, together with
cash on hand, to redeem all of its outstanding 9.25% Senior Secured
First Lien Notes due 2024 and $50.0
million aggregate principal amount of its outstanding 11.00%
Senior Notes due 2025 (the "2025 Notes").
Operations Summary
The following table sets forth information about the
Partnership's continuing operations. Facility production volume
differs from sales volume due to changes in inventories and the
sale of purchased blendstocks such as ethanol and specialty
blendstocks, as well as the resale of crude oil.
|
|
|
|
|
Three Months Ended
March 31,
|
|
2024
|
|
2023
|
|
(In bpd)
|
Total sales volume
(1)
|
83,602
|
|
76,856
|
Total feedstock runs
(2)
|
71,548
|
|
71,559
|
Facility production:
(3)
|
|
|
|
Specialty Products and
Solutions:
|
|
|
|
Lubricating
oils
|
11,187
|
|
10,297
|
Solvents
|
7,179
|
|
8,321
|
Waxes
|
1,407
|
|
1,375
|
Fuels, asphalt and
other by-products
|
31,915
|
|
34,473
|
Total Specialty
Products and Solutions
|
51,688
|
|
54,466
|
Montana/Renewables:
|
|
|
|
Gasoline
|
3,547
|
|
4,406
|
Diesel
|
2,703
|
|
2,651
|
Jet fuel
|
355
|
|
509
|
Asphalt, heavy fuel
oils and other
|
4,147
|
|
4,229
|
Renewable
fuels
|
8,243
|
|
5,030
|
Total
Montana/Renewables
|
18,995
|
|
16,825
|
|
|
|
|
Performance
Brands
|
1,583
|
|
1,931
|
|
|
|
|
Total facility
production (3)
|
72,266
|
|
73,222
|
_______________________
(1)
|
Total sales volume
includes sales from the production at our facilities and certain
third-party facilities pursuant to supply and/or processing
agreements, sales of inventories and the resale of crude oil to
third-party customers. Total sales volume includes the sale of
purchased blendstocks.
|
(2)
|
Total feedstock runs
represent the barrels per day of crude oil and other feedstocks
processed at our facilities and at certain third-party facilities
pursuant to supply and/or processing agreements.
|
(3)
|
The difference between
total facility production and total feedstock runs is primarily a
result of the time lag between the input of feedstocks and
production of finished products and volume loss.
|
Webcast Information
A conference call is scheduled for 9:00
a.m. ET on May 10, 2024 to
discuss the financial and operational results for the first quarter
of 2024. Investors, analysts and members of the media interested in
listening to the live presentation are encouraged to join a webcast
of the call with accompanying presentation slides, available on the
Partnership's website at
www.calumetspecialty.investorroom.com/events. Interested parties
may also participate in the call by dialing (844) 695-5524. A
replay of the conference call will be available a few hours after
the event on the investor relations section of the Partnership's
website, under the events and presentations section and will remain
available for at least 90 days.
About the Partnership
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT)
manufactures, formulates, and markets a diversified slate of
specialty branded products and renewable fuels to customers across
a broad range of consumer-facing and industrial markets. Calumet is
headquartered in Indianapolis,
Indiana and operates twelve facilities throughout
North America.
Additional Information and Where to Find It
This communication relates to the proposed corporate
reorganization between the Partnership and Calumet, Inc. ("New
Calumet"). This communication may be deemed to be solicitation
material in respect of the proposed corporate transition of the
Partnership to New Calumet, a newly formed Delaware corporation (the "Conversion"). The
proposed Conversion will be submitted to the Partnership's
unitholders for their consideration. In connection with the
proposed Conversion, the Partnership and New Calumet have prepared
and filed with the SEC a registration statement on Form S-4 (the
"Form S-4") containing a proxy statement/prospectus (the "Proxy
Statement/Prospectus") to be distributed to the Partnership's
unitholders in connection with the Partnership's solicitation of
proxies for the vote of the Partnership's unitholders in connection
with the proposed Conversion and other matters as described in such
Proxy Statement/Prospectus. The Proxy Statement/Prospectus will
also serve as the prospectus relating to the offer of the
securities to be issued to the equityholders of the Partnership and
Calumet GP, LLC (the "General Partner") in connection with the
completion of the proposed Conversion. The Partnership and New
Calumet may file other relevant documents with the SEC regarding
the proposed Conversion. The definitive Proxy Statement/Prospectus
will be mailed to the Partnership's unitholders when available.
BEFORE MAKING ANY VOTING OR INVESTMENT DECISION WITH RESPECT TO THE
PROPOSED CONVERSION, INVESTORS AND UNITHOLDERS AND OTHER INTERESTED
PERSONS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT/PROSPECTUS
REGARDING THE PROPOSED CONVERSION (INCLUDING ANY AMENDMENTS OR
SUPPLEMENTS THERETO) AND OTHER RELEVANT MATERIALS CAREFULLY AND IN
THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN
IMPORTANT INFORMATION ABOUT THE PROPOSED CONVERSION.
The Proxy Statement/Prospectus, any amendments or supplements
thereto and other relevant materials, and any other documents filed
by the Partnership or New Calumet with the SEC, may be obtained
once such documents are filed with the SEC free of charge at the
SEC's website at www.sec.gov or free of charge from the
Partnership at www.calumet.com or by directing a written
request to the Partnership at 2780 Waterfront Parkway East Drive,
Indianapolis, Indiana 46214.
No Offer or Solicitation
This communication does not constitute an offer to sell or the
solicitation of an offer to buy any securities, or a solicitation
of any vote or approval, nor shall there be any sale of securities
in any jurisdiction in which such offer, solicitation or sale would
be unlawful prior to registration or qualification under the
securities laws of any such jurisdiction. No offering of securities
shall be made except by means of a prospectus meeting the
requirements of Section 10 of the Securities Act of 1933, as
amended.
Participants in the Solicitation
The Partnership, the General Partner and certain of the General
Partner's executive officers, directors, other members of
management and employees may, under the rules of the SEC, be deemed
to be "participants" in the solicitation of proxies in connection
with the proposed Conversion. Information regarding the General
Partner's directors and executive officers is available in the
Partnership's Annual Report on Form 10-K for the year ended
December 31, 2023, which was filed
with the SEC on February 29, 2024
(the "Annual Report"). To the extent that holdings of the
Partnership's securities have changed from the amounts reported in
the Annual Report, such changes have been or will be reflected on
Statements of Changes in Beneficial Ownership on Form 4 filed with
the SEC. These documents may be obtained free of charge from the
sources indicated above. Information regarding the participants in
the proxy solicitation and a description of their direct and
indirect interests, by security holdings or otherwise, are
contained, or will be contained, in the Form S-4, the Proxy
Statement/Prospectus and other relevant materials relating to the
proposed Conversion filed or to be filed with the SEC when they
become available. Unitholders and other investors should read the
Proxy Statement/Prospectus carefully when it becomes available
before making any voting or investment decisions.
Cautionary Statement Regarding Forward-Looking
Statements
Certain statements and information in this press release may
constitute "forward-looking statements." The words "will," "may,"
"intend," "believe," "expect," "outlook," "forecast," "anticipate,"
"estimate," "continue," "plan," "should," "could," "would," or
other similar expressions are intended to identify forward-looking
statements, which are generally not historical in nature. The
statements discussed in this press release that are not purely
historical data are forward-looking statements, including, but not
limited to, the statements regarding (i) demand for finished
products in markets we serve, (ii) our expectation regarding our
business outlook and cash flows, including with respect to the
Montana Renewables business and our plans to de-leverage our
balance sheet, (iii) our expectation regarding anticipated capital
expenditures and strategic initiatives, (iv) our ability to meet
our financial commitments, debt service obligations, debt
instrument covenants, contingencies and anticipated capital
expenditures, (v) the expected benefits of the Conversion to the
Partnership and its unitholders and (vi) the anticipated completion
of the Conversion and the timing thereof. These forward-looking
statements are based on our current expectations and beliefs
concerning future developments and their potential effect on us.
While management believes that these forward-looking statements are
reasonable as and when made, there can be no assurance that future
developments affecting us will be those that we anticipate. All
comments concerning our current expectations for future sales and
operating results are based on our forecasts for our existing
operations and do not include the potential impact of any future
acquisition or disposition transactions. Our forward-looking
statements involve significant risks and uncertainties (some of
which are beyond our control) and assumptions that could cause our
actual results to differ materially from our historical experience
and our present expectations or projections. Known material factors
that could cause actual results to differ materially from those in
the forward-looking statements include: the overall demand for
specialty products, fuels, renewable fuels and other refined
products; the level of foreign and domestic production of crude oil
and refined products; our ability to produce specialty products,
fuel products, and renewable fuel products that meet our customers'
unique and precise specifications; the marketing of alternative and
competing products; the impact of fluctuations and rapid increases
or decreases in crude oil and crack spread prices, including the
resulting impact on our liquidity; the results of our hedging and
other risk management activities; our ability to comply with
financial covenants contained in our debt instruments; the
availability of, and our ability to consummate, acquisition or
combination opportunities and the impact of any completed
acquisitions; labor relations; our access to capital to fund
expansions, acquisitions and our working capital needs and our
ability to obtain debt or equity financing on satisfactory terms;
successful integration and future performance of acquired assets,
businesses or third-party product supply and processing
relationships; our ability to timely and effectively integrate the
operations of acquired businesses or assets, particularly those in
new geographic areas or in new lines of business; environmental
liabilities or events that are not covered by an indemnity,
insurance or existing reserves; maintenance of our credit ratings
and ability to receive open credit lines from our suppliers; demand
for various grades of crude oil and resulting changes in pricing
conditions; fluctuations in refinery capacity; our ability to
access sufficient crude oil supply through long-term or
month-to-month evergreen contracts and on the spot market; the
effects of competition; continued creditworthiness of, and
performance by, counterparties; the impact of current and future
laws, rulings and governmental regulations, including guidance
related to the Dodd-Frank Wall Street Reform and Consumer
Protection Act; the costs of complying with the Renewable Fuel
Standard, including the prices paid for renewable identification
numbers ("RINs"); shortages or cost increases of power supplies,
natural gas, materials or labor; hurricane or other weather
interference with business operations; our ability to access the
debt and equity markets; accidents or other unscheduled shutdowns;
and general economic, market, business or political conditions,
including inflationary pressures, instability in financial
institutions, the prospect of a shutdown of the U.S. federal
government, general economic slowdown or a recession, political
tensions, conflicts and war (such as the ongoing conflicts in
Ukraine and the Middle East and their regional and global
ramifications).
For additional information regarding factors that could cause
our actual results to differ from our projected results, please see
our filings with the SEC, including the risk factors and other
cautionary statements in our latest Annual Report on Form 10-K and
other filings with the SEC.
We caution that these statements are not guarantees of future
performance and you should not rely unduly on them, as they involve
risks, uncertainties, and assumptions that we cannot predict. In
addition, we have based many of these forward-looking statements on
assumptions about future events that may prove to be inaccurate.
While our management considers these assumptions to be reasonable,
they are inherently subject to significant business, economic,
competitive, regulatory and other risks, contingencies and
uncertainties, most of which are difficult to predict and many of
which are beyond our control. Accordingly, our actual results may
differ materially from the future performance that we have
expressed or forecast in our forward-looking statements. Readers
are cautioned not to place undue reliance on forward-looking
statements, which speak only as of the date they are made. We
undertake no obligation to publicly update or revise any
forward-looking statements after the date they are made, whether as
a result of new information, future events or otherwise, except to
the extent required by applicable law. Certain public statements
made by us and our representatives on the date hereof may also
contain forward-looking statements, which are qualified in their
entirety by the cautionary statements contained above.
Non-GAAP Financial Measures
Our management uses certain non-GAAP performance measures to
analyze operating segment performance and non-GAAP financial
measures to evaluate past performance and prospects for the future
to supplement our financial information presented in accordance
with generally accepted accounting principles ("GAAP"). These
financial and operational non-GAAP measures are important factors
in assessing our operating results and profitability and include
performance measures along with certain key operating metrics.
We use the following financial performance measures:
EBITDA: We define EBITDA for any period as net income (loss)
plus interest expense (including amortization of debt issuance
costs), income taxes and depreciation and amortization.
Historically, we considered net income (loss) to be the most
directly comparable GAAP measure to EBITDA. We believe net income
(loss) is the most directly comparable GAAP measure to EBITDA.
Adjusted EBITDA: We define Adjusted EBITDA for any period as:
EBITDA adjusted for (a) impairment; (b) unrealized gains and
losses from mark to market accounting for hedging activities;
(c) realized gains and losses under derivative instruments
excluded from the determination of net income (loss);
(d) non-cash equity-based compensation expense and other
non-cash items (excluding items such as accruals of cash expenses
in a future period or amortization of a prepaid cash expense) that
were deducted in computing net income (loss); (e) debt
refinancing fees, extinguishment costs, premiums and penalties; (f)
any net gain or loss realized in connection with an asset sale that
was deducted in computing net income (loss); (g) amortization of
turnaround costs; (h) LCM inventory adjustments; (i) the impact of
liquidation of inventory layers calculated using the LIFO method;
(j) RINs mark-to-market adjustments; and (k) all
extraordinary, unusual or non-recurring items of gain or loss, or
revenue or expense.
Distributable Cash Flow: We define Distributable Cash Flow for
any period as Adjusted EBITDA less replacement and environmental
capital expenditures, turnaround costs, cash interest expense
(consolidated interest expense less non-cash interest expense),
gain (loss) from unconsolidated affiliates, net of cash
distributions and income tax expense (benefit).
Specialty Products and Solutions segment Adjusted EBITDA Margin:
We define Specialty Products and Solutions segment Adjusted EBITDA
Margin for any period as Specialty Products and Solutions segment
Adjusted EBITDA divided by Specialty Products and Solutions segment
sales.
The definition of Adjusted EBITDA that is presented in this
press release is similar to the calculation of (i) "Consolidated
Cash Flow" contained in the indentures governing the 2025 Notes,
our 8.125% Senior Notes due 2027 (the "2027 Notes"), our 9.75%
Senior Notes due 2028 (the "2028 Notes"), and our 9.25% Senior
Secured First Lien Notes due 2029 (the "2029 Secured Notes") and
(ii) "Consolidated EBITDA" contained in the credit agreement
governing our revolving credit facility. We are required to report
Consolidated Cash Flow to the holders of our 2025 Notes, 2027
Notes, 2028 Notes, and 2029 Secured Notes and Consolidated EBITDA
to the lenders under our revolving credit facility, and these
measures are used by them to determine our compliance with certain
covenants governing those debt instruments. Please see our filings
with the SEC, including our most recent Annual Report on Form 10-K
and Current Reports on Form 8-K, for additional details regarding
the covenants governing our debt instruments.
These non-GAAP measures are used as supplemental financial
measures by our management and by external users of our financial
statements such as investors, commercial banks, research analysts
and others, to assess:
- the financial performance of our assets without regard to
financing methods, capital structure or historical cost basis;
- the ability of our assets to generate cash sufficient to pay
interest costs and support our indebtedness;
- our operating performance and return on capital as compared to
those of other companies in our industry, without regard to
financing or capital structure;
- the viability of acquisitions and capital expenditure projects
and the overall rates of return on alternative investment
opportunities; and
- our operating performance excluding the non-cash impact of LCM
and LIFO inventory adjustments, RINs mark-to-market adjustments,
and depreciation and amortization.
We believe that these non-GAAP measures are useful to analysts
and investors, as they exclude transactions not related to our core
cash operating activities and provide metrics to analyze our
ability to fund our capital requirements and to pay interest on our
debt obligations. We believe that excluding these transactions
allows investors to meaningfully analyze trends and performance of
our core cash operations.
EBITDA, Adjusted EBITDA, and Distributable Cash Flow should not
be considered alternatives to Net income (loss), Operating income
(loss), Net cash provided by (used in) operating activities, gross
profit (loss) or any other measure of financial performance
presented in accordance with GAAP. In evaluating our performance as
measured by EBITDA, Adjusted EBITDA, and Distributable Cash Flow
management recognizes and considers the limitations of these
measurements. EBITDA and Adjusted EBITDA do not reflect our
liabilities for the payment of income taxes, interest expense or
other obligations such as capital expenditures. Accordingly,
EBITDA, Adjusted EBITDA, and Distributable Cash Flow are only a few
of several measurements that management utilizes. Moreover, our
EBITDA, Adjusted EBITDA, and Distributable Cash Flow may not be
comparable to similarly titled measures of another company because
all companies may not calculate EBITDA, Adjusted EBITDA, and
Distributable Cash Flow in the same manner. Please see the section
of this release entitled "Non-GAAP Reconciliations" for tables that
present reconciliations of EBITDA, Adjusted EBITDA, and
Distributable Cash Flow to Net income (loss), our most directly
comparable GAAP financial performance measure.
CALUMET SPECIALTY
PRODUCTS PARTNERS, L.P.
UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions,
except unit and per unit data)
|
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
2024
|
|
2023
|
|
|
|
|
(As restated)
|
Sales
|
$
|
1,005.8
|
|
$
|
1,037.3
|
Cost of
sales
|
|
927.3
|
|
|
940.7
|
Gross profit
|
|
78.5
|
|
|
96.6
|
Operating costs and
expenses:
|
|
|
|
|
|
Selling
|
|
13.7
|
|
|
13.5
|
General and
administrative
|
|
23.3
|
|
|
37.1
|
Other operating
expense
|
|
5.2
|
|
|
3.0
|
Operating
income
|
|
36.3
|
|
|
43.0
|
Other income
(expense):
|
|
|
|
|
|
Interest
expense
|
|
(60.8)
|
|
|
(49.2)
|
Gain (loss) on
derivative instruments
|
|
(16.9)
|
|
|
25.5
|
Other
expense
|
|
—
|
|
|
(0.2)
|
Total other
expense
|
|
(77.7)
|
|
|
(23.9)
|
Net income (loss)
before income taxes
|
|
(41.4)
|
|
|
19.1
|
Income tax
expense
|
|
0.2
|
|
|
0.5
|
Net income
(loss)
|
$
|
(41.6)
|
|
$
|
18.6
|
Allocation of net
income (loss) to partners
|
|
|
|
|
|
Net income (loss)
attributable to partners
|
$
|
(41.6)
|
|
$
|
18.6
|
Less:
|
|
|
|
|
|
General partner's
interest in net income (loss)
|
|
(0.8)
|
|
|
0.4
|
Net income (loss)
attributable to limited partners
|
$
|
(40.8)
|
|
$
|
18.2
|
Weighted average
limited partner units outstanding:
|
|
|
|
|
|
Basic
|
|
80,352,403
|
|
|
79,830,671
|
Diluted
|
|
80,352,403
|
|
|
79,939,985
|
Limited partners'
interest basic net income (loss) per unit:
|
|
|
|
|
|
Limited partners'
interest
|
$
|
(0.51)
|
|
$
|
0.23
|
Limited partners'
interest diluted net income (loss) per unit:
|
|
|
|
|
|
Limited partners'
interest
|
$
|
(0.51)
|
|
$
|
0.23
|
CALUMET SPECIALTY
PRODUCTS PARTNERS, L.P.
CONDENSED
CONSOLIDATED BALANCE SHEETS
(In
millions)
|
|
|
|
|
|
|
|
|
|
March 31, 2024
|
|
December 31, 2023
|
ASSETS
|
|
(Unaudited)
|
|
|
Current
assets:
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
23.9
|
|
$
|
7.9
|
Accounts
receivable
|
|
|
|
|
|
|
Trade, less allowance
for credit losses of $1.4 million and $1.2 million,
respectively
|
|
|
289.4
|
|
|
252.4
|
Other
|
|
|
49.6
|
|
|
33.8
|
|
|
|
339.0
|
|
|
286.2
|
Inventories
|
|
|
403.1
|
|
|
439.4
|
Derivative
assets
|
|
|
5.5
|
|
|
9.6
|
Prepaid expenses and
other current assets
|
|
|
40.2
|
|
|
51.6
|
Total current
assets
|
|
|
811.7
|
|
|
794.7
|
Property, plant and
equipment, net
|
|
|
1,486.0
|
|
|
1,506.3
|
Other noncurrent
assets, net
|
|
|
433.9
|
|
|
450.3
|
Total assets
|
|
$
|
2,731.6
|
|
$
|
2,751.3
|
LIABILITIES AND PARTNERS' CAPITAL
(DEFICIT)
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
Accounts
payable
|
|
$
|
321.1
|
|
$
|
322.0
|
Accrued interest
payable
|
|
|
41.3
|
|
|
48.7
|
Accrued salaries, wages
and benefits
|
|
|
68.4
|
|
|
87.1
|
Obligations under
inventory financing agreements
|
|
|
55.6
|
|
|
190.4
|
Current portion of RINs
obligation
|
|
|
212.7
|
|
|
277.3
|
Other current
liabilities
|
|
|
99.0
|
|
|
131.5
|
Current portion of
long-term debt
|
|
|
26.3
|
|
|
55.7
|
Total current
liabilities
|
|
|
824.4
|
|
|
1,112.7
|
Other long-term
liabilities
|
|
|
135.7
|
|
|
53.6
|
Long-term debt, less
current portion
|
|
|
2,055.6
|
|
|
1,829.7
|
Total
liabilities
|
|
$
|
3,015.7
|
|
$
|
2,996.0
|
Commitments and
contingencies
|
|
|
|
|
|
|
Redeemable
noncontrolling interest
|
|
$
|
245.6
|
|
$
|
245.6
|
Partners' capital
(deficit):
|
|
|
|
|
|
|
Limited partners'
interest (80,223,093 units and 79,967,363 units, issued and
outstanding at March 31, 2024 and December 31, 2023,
respectively)
|
|
$
|
(523.1)
|
|
$
|
(484.4)
|
General partner's
interest
|
|
|
0.5
|
|
|
1.3
|
Accumulated other
comprehensive loss
|
|
|
(7.1)
|
|
|
(7.2)
|
Total partners' capital
(deficit)
|
|
|
(529.7)
|
|
|
(490.3)
|
Total liabilities and
partners' capital (deficit)
|
|
$
|
2,731.6
|
|
$
|
2,751.3
|
CALUMET SPECIALTY
PRODUCTS PARTNERS, L.P.
UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In
millions)
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
|
2024
|
|
2023
|
|
|
(In millions)
|
Operating activities
|
|
|
|
|
(As Restated)
|
Net income
(loss)
|
|
$
|
(41.6)
|
|
$
|
18.6
|
Non-cash RINs
gain
|
|
|
(64.6)
|
|
|
(32.1)
|
Unrealized (gain) loss
on derivative instruments
|
|
|
17.5
|
|
|
(41.0)
|
Other non-cash
activities
|
|
|
47.8
|
|
|
66.3
|
Changes in assets and
liabilities
|
|
|
(53.1)
|
|
|
(38.5)
|
Net cash used in
operating activities
|
|
|
(94.0)
|
|
|
(26.7)
|
Investing activities
|
|
|
|
|
|
|
Additions to property,
plant and equipment
|
|
|
(20.0)
|
|
|
(130.4)
|
Net cash used in
investing activities
|
|
|
(20.0)
|
|
|
(130.4)
|
Financing activities
|
|
|
|
|
|
|
Proceeds from
borrowings — revolving credit facility
|
|
|
596.8
|
|
|
559.0
|
Repayments of
borrowings — revolving credit facility
|
|
|
(423.7)
|
|
|
(437.0)
|
Proceeds from
borrowings — MRL revolving credit agreement
|
|
|
32.0
|
|
|
18.7
|
Repayments of
borrowings — MRL revolving credit agreement
|
|
|
(22.3)
|
|
|
—
|
Proceeds from
borrowings — senior notes
|
|
|
200.0
|
|
|
—
|
Repayments of
borrowings — senior notes
|
|
|
(179.0)
|
|
|
—
|
Proceeds from inventory
financing
|
|
|
280.7
|
|
|
388.5
|
Payments on inventory
financing
|
|
|
(336.8)
|
|
|
(404.1)
|
Proceeds from other
financing obligations
|
|
|
—
|
|
|
20.8
|
Payments on other
financing obligations
|
|
|
(17.0)
|
|
|
(12.8)
|
Net cash provided by
financing activities
|
|
|
130.7
|
|
|
133.1
|
Net increase (decrease)
in cash, cash equivalents and restricted cash
|
|
|
16.7
|
|
|
(24.0)
|
Cash, cash equivalents
and restricted cash at beginning of period
|
|
|
14.7
|
|
|
35.2
|
Cash, cash equivalents
and restricted cash at end of period
|
|
$
|
31.4
|
|
$
|
11.2
|
Cash and cash
equivalents
|
|
$
|
23.9
|
|
$
|
11.2
|
Restricted
cash
|
|
$
|
7.5
|
|
$
|
—
|
Supplemental disclosure of non-cash investing
activities
|
|
|
|
|
|
|
Non-cash property,
plant and equipment additions
|
|
$
|
25.2
|
|
$
|
95.1
|
CALUMET SPECIALTY
PRODUCTS PARTNERS, L.P.
NON-GAAP
RECONCILIATIONS
RECONCILIATION OF
NET INCOME (LOSS)
TO EBITDA,
ADJUSTED EBITDA AND DISTRIBUTABLE CASH FLOW
(In
millions)
|
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
2024
|
|
2023
|
|
(In millions)
|
|
(Unaudited)
|
Reconciliation of Net income (loss) to EBITDA,
Adjusted EBITDA and Distributable Cash Flow:
|
|
|
|
|
|
Net income
(loss)
|
$
|
(41.6)
|
|
$
|
18.6
|
Add:
|
|
|
|
|
|
Interest
expense
|
|
60.8
|
|
|
49.2
|
Depreciation and
amortization
|
|
36.0
|
|
|
29.5
|
Income tax
expense
|
|
0.2
|
|
|
0.5
|
EBITDA
|
$
|
55.4
|
|
$
|
97.8
|
Add:
|
|
|
|
|
|
LCM / LIFO
loss
|
$
|
9.0
|
|
$
|
19.7
|
Unrealized gain on
derivative instruments
|
|
(35.7)
|
|
|
(41.0)
|
Debt extinguishment
costs
|
|
0.2
|
|
|
—
|
Amortization of
turnaround costs
|
|
9.4
|
|
|
7.7
|
RINs mark-to-market
gain
|
|
(71.1)
|
|
|
(46.1)
|
Equity-based
compensation and other items
|
|
(7.3)
|
|
|
9.0
|
Other non-recurring
expenses (1)
|
|
60.8
|
|
|
29.5
|
Noncontrolling
interest adjustments
|
|
0.9
|
|
|
0.7
|
Adjusted
EBITDA
|
$
|
21.6
|
|
$
|
77.3
|
Less:
|
|
|
|
|
|
Replacement and
environmental capital expenditures (2)
|
$
|
16.7
|
|
$
|
17.2
|
Cash interest expense
(3)
|
|
58.8
|
|
|
47.7
|
Turnaround
costs
|
|
5.5
|
|
|
7.1
|
Income tax
expense
|
|
0.2
|
|
|
0.5
|
Distributable Cash
Flow
|
$
|
(59.6)
|
|
$
|
4.8
|
_____________________________
(1)
|
For the three months
ended March 31, 2024, other non-recurring expenses included a $51.9
million realized loss on derivatives related to the embedded
derivatives for our inventory financing arrangements. For the three
months ended March 31, 2023, other non-recurring expenses included
a $28.4 million charge to cost of sales for losses under firm
purchase commitments.
|
(2)
|
Replacement capital
expenditures are defined as those capital expenditures which do not
increase operating capacity or reduce operating costs and exclude
turnaround costs. Environmental capital expenditures include asset
additions to meet or exceed environmental and operating
regulations.
|
(3)
|
Represents consolidated
interest expense less non-cash interest expense.
|
Contact for Investors:
John Kompa
john.kompa@calumetspecialty.com
317-957-5237
Contact for Media:
Media Oakes
media.oakes@calumetspecialty.com
317-957-5319
View original
content:https://www.prnewswire.com/news-releases/calumet-specialty-products-partners-lp-reports-first-quarter-2024-results-302142258.html
SOURCE Calumet Specialty Products Partners, L.P.